Johanna Friedl-Naderer - Insider Trading & Ownership

Entity
Individual
Location
C/O Vir Biotechnology, Inc., 499 Illinois Street, Suite 500, San Francisco, CA
Summary
The estimated net worth of Johanna Friedl-Naderer is at least $3.02M dollars as of December 6, 2024. Johanna Friedl-Naderer is the Chief Commercial Officer of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $2.79M. Johanna Friedl-Naderer is the EVP & Chief Operating Officer of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $227K.
All Insider Reports
All Insider Reports

Ownership of Johanna Friedl-Naderer

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DYN Dyne Therapeutics, Inc. Chief Commercial Officer $2.79M Dec 4, 2024
VIR Vir Biotechnology, Inc. EVP & Chief Operating Officer $227K Mar 3, 2023

Insider Transactions Reported by Johanna Friedl-Naderer:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.